Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
297.50 DKK | +1.85% |
|
+6.75% | -8.24% |
07-15 | European shares fall on healthcare, financials drag; focus on US-EU trade deal | RE |
07-15 | European shares fall on healthcare, financials drag; focus on US-EU trade deal | RE |
Company Valuation: Orsted A/S
Data adjusted to current consolidation scope
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 522,352 | 350,930 | 265,253 | 157,272 | 136,239 | 122,749 | - | - |
Change | - | -32.82% | -24.41% | -40.71% | -13.37% | -9.9% | - | - |
Enterprise Value (EV) 1 | 534,695 | 375,210 | 295,824 | 204,651 | 194,266 | 201,938 | 204,643 | 204,513 |
Change | - | -29.83% | -21.16% | -30.82% | -5.07% | 3.95% | 1.34% | -0.06% |
P/E ratio | 32x | 34.4x | 18.2x | -7.47x | -147x | 13x | 10.9x | 10.8x |
PBR | 5.52x | 4.28x | 2.9x | 2.07x | 2.19x | 1.4x | 1.23x | 1.12x |
PEG | - | -0.9x | 0.4x | 0x | 1.5x | -0x | 0.6x | 11.18x |
Capitalization / Revenue | 9.93x | 4.52x | 2.01x | 1.98x | 1.92x | 1.65x | 1.49x | 1.47x |
EV / Revenue | 10.2x | 4.83x | 2.24x | 2.58x | 2.73x | 2.72x | 2.49x | 2.45x |
EV / EBITDA | 29.5x | 15.4x | 9.23x | 10.9x | 6.08x | 7.17x | 6.34x | 6.18x |
EV / EBIT | 50.7x | 23.2x | 15x | -11.5x | 31.5x | 11.7x | 9.9x | 10.5x |
EV / FCF | 62.6x | -16.7x | -14x | 13.1x | -8x | -5.53x | -7.32x | -29.4x |
FCF Yield | 1.6% | -5.98% | -7.13% | 7.62% | -12.5% | -18.1% | -13.7% | -3.4% |
Dividend per Share 2 | 11.5 | 12.5 | 13.5 | - | - | 16.78 | 18.04 | 12.3 |
Rate of return | 0.92% | 1.5% | 2.14% | - | - | 5.75% | 6.18% | 4.21% |
EPS 2 | 38.8 | 24.3 | 34.6 | -50.1 | -2.2 | 22.49 | 26.75 | 27 |
Distribution rate | 29.6% | 51.4% | 39% | - | - | 74.6% | 67.5% | 45.6% |
Net sales 1 | 52,601 | 77,673 | 132,277 | 79,255 | 71,034 | 74,311 | 82,116 | 83,520 |
EBITDA 1 | 18,124 | 24,296 | 32,057 | 18,717 | 31,959 | 28,152 | 32,262 | 33,083 |
EBIT 1 | 10,536 | 16,195 | 19,774 | -17,853 | 6,171 | 17,294 | 20,674 | 19,566 |
Net income 1 | 16,289 | 10,962 | 14,549 | -21,059 | -923 | 9,489 | 11,498 | 10,877 |
Net Debt 1 | 12,343 | 24,280 | 30,571 | 47,379 | 58,027 | 79,189 | 81,894 | 81,764 |
Reference price 2 | 1,243.50 | 835.20 | 631.30 | 374.30 | 324.20 | 292.10 | 292.10 | 292.10 |
Nbr of stocks (in thousands) | 420,066 | 420,175 | 420,170 | 420,175 | 420,230 | 420,230 | - | - |
Announcement Date | 03/02/21 | 02/02/22 | 01/02/23 | 07/02/24 | 06/02/25 | - | - | - |
1DKK in Million2DKK
Estimates
P/E ratio, Detailed evolution
P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
---|---|---|---|---|---|---|
12.99x | 2.59x | 7.17x | -.--% | 19.07B | ||
75.79x | 3.97x | 45.33x | 0.18% | 156B | ||
21.69x | 8.58x | 14.28x | 3.02% | 155B | ||
16.4x | 3.11x | 9.18x | 4.31% | 109B | ||
21.87x | 6.14x | 13.7x | 3.16% | 103B | ||
38.05x | 4.38x | 21.01x | 0.5% | 96.56B | ||
11.67x | 1.64x | 6.03x | 6.08% | 92.83B | ||
18.74x | 5.35x | 11.25x | 3.65% | 91.3B | ||
31.62x | 3.85x | 13.24x | 0.51% | 61.76B | ||
18.09x | 4.86x | 11.73x | 3.56% | 56.59B | ||
Average | 26.69x | 4.45x | 15.29x | 2.5% | 94.04B | |
Weighted average by Cap. | 30.71x | 4.83x | 17.98x | 2.63% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- ORSTED Stock
- Valuation Orsted A/S
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition